Imfinzi, AstraZeneca’s blockbuster medicine, has received FDA permission for extended use in non-small cell lung cancer (NSCLC), marking a significant …
Recently, Novartis, a multinational pharmaceutical corporation with headquarters in Switzerland, suffered a serious legal setback in its fight against MSN …
Pfizer and BioNTech recently announced that their experimental mRNA-based combination vaccine, which was supposed to protect against both influenza and …